The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Michael R. Edwards
Department of Respiratory Medicine
St Mary's Hospital
National Heart Lung Institute
Imperial College London
UK
Name/email consistency: high
- Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Edwards, M.R., Bartlett, N.W., Clarke, D., Birrell, M., Belvisi, M., Johnston, S.L. Pharmacol. Ther. (2009)
- Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. Edwards, M.R., Haas, J., Panettieri, R.A., Johnson, M., Johnston, S.L. J. Biol. Chem. (2007)
- Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Edwards, M.R., Hewson, C.A., Laza-Stanca, V., Lau, H.T., Mukaida, N., Hershenson, M.B., Johnston, S.L. Mol. Immunol. (2007)
- New treatment regimes for virus-induced exacerbations of asthma. Edwards, M.R., Kebadze, T., Johnson, M.W., Johnston, S.L. Pulm. Pharmacol. Ther (2006)
- Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. Edwards, M.R., Johnson, M.W., Johnston, S.L. Am. J. Respir. Cell Mol. Biol. (2006)
- IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids. Edwards, M.R., Mukaida, N., Johnson, M., Johnston, S.L. Pulm. Pharmacol. Ther (2005)
